Effect of allopurinol on cardiac biomarkers in patients undergoing elective percutaneous coronary interventio
Not Applicable
- Conditions
- coronary artery disease.Atherosclerotic heart disease
- Registration Number
- IRCT201210018698N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
patients who are candidates for elective PCI.
Exclusion criteria: patients who are candidates for CABG or Primary PCI; Glomerular filtration rate less than 60 ml / min or serum creatinine more than 3 mg / dl; history of gout; taking allopurinol; severe liver disease; concomitant use of azathioprine, 6 - mercaptopurine or warfarin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CTnT. Timepoint: before of intervention, one day after intervention. Method of measurement: ng/ml.;CKMB. Timepoint: before of intervention, one day after intervention. Method of measurement: ng/ml.
- Secondary Outcome Measures
Name Time Method